Ocugen, Inc. Made Headway

Ocugen, Inc. (OCGN:NASDAQ) shot up at $0.38, a gain of 23.9%. On Wed 02 Sep 20, OCGN:NASDAQ touched a New 2-Week Low of $0.31. The stock got featured on our News Catalysts scanner on Thu 03 Sep 20 at 07:43 AM in the 'MISCELLANEOUS' category. From Wed 19 Aug 20, the stock recorded 10.00% Up Days and 18.18% Green Days

The stock spiked on Mon 10 Aug 20 at $0.8 with a volume of 106M+.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).